BRAND_ANALYSIS #SANOFI HEALTH & PHARMA #20 OF 26 IN HEALTH & PHARMA ALIGNED

Sanofi

· Private · Updated 09 Apr 2026 08:47 UTC
#747 of 1208 overall by tension · #20 of 26 in Health & Pharma
12 Aligned
The Balanced
Analysis

Pharma's reputation lag. C=50, sentiment 0.45—Sanofi's sentiment score reflects the industry's broader problem: essential goods, structural distrust. The company makes products people need but won't celebrate. That's the pharma ceiling.

IN THE NEWS (83 articles this week)
Sanofi’s bispecific scores double respiratory phase 2 wins, but flunks eczema study - Fierce Biotech
With Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engine - Fierce Pharma
The Fast (And Intense) Lane: How Expedited Approvals Are Going Further and Faster for Patients - Sanofi
Cultural Score
50 / 100
Business Score
62 / 100
TENSION▁▁▁▁▁▁▁▁▁▁▁▁▁▁
CULTURAL▄▄▄▄▄▄▄▄▄▄▄▄▄▄
BUSINESS▅▅▅▅▅▅▅▅▅▄▅▅▅▅
Loading...
Wikipedia Momentum 15/40
News Presence 36/35
Search InterestRedistributed to other dimensions
Stock Momentum 0/30
Market Position 0/25
Revenue Growth 0/25
Earnings Health 0/20
Sanofi's tension is 12. Commerce outpacing culture. sociologyofcapitalism.com/brand/sanofi
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/sanofi.html" width="320" height="200" frameborder="0"></iframe>